Septerna's Chief People Officer Sold Nearly 12,000 Company Shares. What Does That Mean for Investors?

Septerna's Chief People Officer Samira Shaikhly sold 11,798 shares worth approximately $355,000 on May 26, 2026, reducing her direct holdings by 93.7%. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted in October 2025, indicating a non-discretionary transaction designed to avoid insider trading accusations. Despite the large insider sale, the company reported positive clinical trial progress and maintains strong cash reserves of $522.1 million, sufficient to fund operations into 2029.